SEARCH · Engineering Papers

Results for “Pharmaceuticals”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 631 records · Page 35

All sources NASA NTRS DOE OSTI

NASA NTRS2013

ESO Commercial Microgravity Case Study 1: Novice Commercial Users (Medical) Vivo Biosciences Inc. - A Small Business Perspective

This case study was conducted in FY 2013 by the Emerging Space Office (ESO) to begin characterizing the kinds of opportunities and challenges encountered by small high-tech businesses who have never done RD in space and who serve terrestrial versus space markets, but who have legitimate business reasons for considering space research and development for generating novel or improved products. Vivo Biosciences Inc. (VBI) is an award winning company with a customer base that includes major pharmaceutical companies. However, despite a continuing series of successes, VBI believes that they are about at the limit of the performance their product can achieve on Earth and gravity is the problem. This Case Study documented VBI's experience as the novice company attempted its first steps in the process of conducting research and development in space. The report presents insights applicable to commercial suppliers of microgravity services as well as ISS support of new commercial users, especially small businesses interested in using space for product development.

Harper, Lynn D.↗

NASA NTRS2019

Synthetic Biology off Planet for Game-Changing Solutions for a Greener Earth

Synthetic biology – creating new capabilities with life – promises to create a greener future for planet Earth, from fields as diverse as pharmaceuticals to manufacturing, agriculture and nanotechnology. Progress can be stymied by such considerations as economics, politics, legal and philosophical issues surrounding GMOs. Often solutions to these problems already exist, so it is difficult for a new, superior method to displace the old. As we move humans beyond Earth, to long duration stays in the International Space Station, and then onward to the Moon and Mars, the challenges of supporting human life will need radical new solutions. While there are new constraints, such as worrying about the mass of a solution, constraints offer opportunities for game-changing solutions that will then allow revolutions back on our home planet.

Rothschild, Lynn J.↗

NASA NTRS2016

On-Orbit Manufacturing From Orbital Factories to In Situ Resource Utilization

This webinar will review commercial prospects for manufacturing in orbit. Doing business in space is rapidly becoming more reliable, affordable and accessible. From 2010 to 2015 launch prices went down by a factor of 10 or more, to about $5,000kg while investments into Space 2.0 companies and technologies are closing in on $2.5 Billion (New Space Global). With three commercial suppliers (SpaceX, Orbital ATK and Sierra Nevada Corp) to Earths orbits, mission frequency is improving dramatically. Moreover, private space companies (SpaceX Reusable Dragon Lab; Bigelows B330) are also scouting the opportunities of renting or selling modules as platforms for orbital free-flying facilities; modules that can be used for automated fabrication to manned experiments.Topics addressed in the webinar include: 1. Case studies of unique competitive advantages that can be gained from microgravity and space vacuum: wafer reprocessing, fiber optics, crystal growth;2. Prospective solar power orbital data centers;3. Reuse and recycling of orbital debris as a possible feedstock for robotic 3D fabrication potentially in the vacuum as well as inside facilities;4. The story behind the original WakeShield wafer fabrication facility and its relevance to todays activities;5. Energy needs for on-orbit manufacturing6. Environmental value proposition of on-orbit manufacturing for products with toxic byproducts or excessively large green house gases footprints;7. Longer term scenario of flexible, connected, automated, intelligent and sustainable orbital factories of the future.Opening up a less-appreciated aspect of NewSpace, this webinar will be of high interest to CTOs, Directors and Managers from product development to RD, Innovation Strategy leaders, and investors, across many different industrial verticals (materials, electronics, pharmaceuticals, advanced sustainable manufacturing, bioengineering, etc.)and anyone trying to understand what value space can have for their business in the near and far future.

Cozmuta, Ioana↗

NASA NTRS2017

Medical Countermeasures for Radiation Induced Health Effects: Reports of an Interagency Panel Session Held at the NASA Human Research Program Investigator's Workshop, January 26, 2017

An Interagency Panel Session organized by the NASA Human Research Program Space Radiation Program Element (SRPE) was held during the NASA Human Research Program (HRP) Investigator’s Workshop (IWS) in Galveston, Texas on January 26, 2017 to identify complementary research areas that will advance the testing and development of medical countermeasures (MCM) in support of radioprotection and radiation mitigation on the ground and in space. There were several areas of common interest identified among the various participating agencies. This report provides a summary of the topics discussed by each agency along with potential areas of intersection for mutual collaboration opportunities. Common goals included repurposing of pharmaceuticals, neutraceuticals for use as radioprotectors and/or mitigators, low-dose/chronic exposure paradigms, late effects post-radiation exposure, mixed-field exposures of gamma-neutron, performance decrements, and methods to determine individual exposure levels.

Carnell, Lisa S.↗

NASA NTRSDate not supplied

Bioreactor Development for CO2-Based In Situ Resource Utilization Manufacturing

Sustainable long-duration manned missions on both the Moon and Mars will require in situ resource utilization (ISRU). Carbon dioxide (CO2) has great potential as a harvestable resource, making up 95% of the atmosphere on Mars and being produced as respiratory waste in spacecraft and future planetary habitats. Through ISRU, biomanufacturing has the capability to produce a near limitless array of products from local space resources, which include pharmaceuticals, bioplastics, chemical feedstocks, and industrial enzymes. Here, a CO2-based ISRU recombinant protein bioreactor and associated biomanufacturing organisms were designed to produce a highly stable carbonic anhydrase (CA). Initial work characterized candidate organisms for growth on acetate and formic acid, carbon substrates that can be synthesized via electrochemical conversion of CO2. To improve growth on the CO2 producing substrate formic acid and for direct integration of ISRU CO2, a synthetic Calvin-Benson-Bassam cycle was designed for use in Cyberlindnera jadinii and Escherichia coli. Genetic modifications in E. coli will be facilitated by a tailored CRISPR/Cas9 and λ red recombineering two-vector system. For expression of CA, a blue light regulated T7 promoter was employed for dynamic and small molecule free induction. Efficient bioproduction through a fed-batch exponential feeding strategy was determined via mass balance calculations from ISRU substrates to biomass and CA yield. Flux balance analysis was used to model ISRU substrate metabolism and metabolic pathway engineering in candidate organisms under cultivation strategy conditions for both metabolism reconstruction and pathway design optimization. Finally, a small-scale, disposable bag bioreactor concept for use in the NASA Bioculture System infrastructure was designed to enable CO2-based CA production in reduced-gravity environments.

Biomanufacturing, Pathway Engineering, Flux Balanc↗

NASA NTRS2020

Electromagnetic Pain Relief/Blocking: Feasibility Assessment

Context/Background: Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves. Objective/Purpose: The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions. Data Sources: Due to the COVID-19 pandemic and the resulting closure of libraries, data sources were restricted to those available digitally. Online database searches included PubMed, U.S. Patent and Trademark Office, federal grant award databases (National Aeronautics and Space Administration (NASA), Department of Defense (DoD), National Institutes of Health (NIH)), and general internet searches. More than 1,600 records were reviewed in this effort. Study Selection/Eligibility Criteria: Targeted searches included different aspects of pain management. Priority was given to review studies, to cover as much of the available literature as possible in this limited effort. Study Appraisal and Synthesis Methods/Data Extraction and Data Synthesis: The titles of the studies and the awards that were obtained by searching online databases were reviewed and further information was sought for the relevant titles. Abstracts or award summaries were generally available online; for journal abstracts, full text articles were either available online or were requested via interlibrary loan. Results: An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified. Limitations: This current effort, although extensive, did not identify a comprehensive list of all alternatives for pain treatment. Once the pandemic limitations are lifted, a longer, more thorough effort may find additional options. Conclusions/Implications: The ideal electromagnetic pain treatment device for use on exploration-class spaceflight missions does not yet exist, but it may be available soon. It is not feasible for NASA to develop medical devices due to the schedule constraints for pending exploration-class missions, but adapting a promising device that is already FDA-approved might be an option. Monitoring research that is ongoing at other federal agencies is recommended, and further review of the candidate PSWT device identified in this current effort may be warranted.

Carol Mullenax↗

NASA NTRS2020

Electromagnetic Pain Relief/Blocking

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation – dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves. The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration-class spaceflight missions.

Carol A. Mullenax↗

NASA NTRS2020

UV/Vis+ Photochemistry Database: Structure, Content and Applications

The “science-softCon UV/Vis+ Photochemistry Database” (www.photochemistry.org) is a large and comprehensive collection of EUV-VUV-UV–Vis-NIR spectral data and other photochemical information assembled from published peer-reviewed papers. The database contains photochemical data including absorption, fluorescence, photoelectron, and circular and linear dichroism spectra, as well as quantum yields and photolysis related data that are critically needed in many scientific disciplines. This manuscript gives an outline regarding the structure and content of the “science-softCon UV/Vis+ Photochemistry Database”. The accurate and reliable molecular level information provided in this database is fundamental in nature and helps in proceeding further to understand photon, electron and ion induced chemistry of molecules of interest not only in spectroscopy, astrochemistry, astrophysics, Earth and planetary sciences, environmental chemistry, plasma physics, combustion chemistry but also in applied fields such as medical diagnostics, pharmaceutical sciences, biochemistry, agriculture, and catalysis. In order to illustrate this, we illustrate the use of the UV/Vis+ Photochemistry Database in four different fields of scientific endeavor.

Photochemistry↗

NASA NTRSDate not supplied

Monitoring Biomarkers for Muscular Atrophy Using an Electrochemical Chip for Astronaut Space Health

Skeletal muscle atrophy is a serious health problem for astronauts in long-duration space flight under microgravity conditions. Preventative measures against muscle atrophy require specific exercise and dietary regimens. Preemptive measurements to improve treatment have the potential to streamline these regimens, decreasing their daily footprint and increasing astronaut quality of life. The objective of our proposed project is to (1) develop a fully integrated disposable microelectrode array chip (with the size of a stamp) that can be interfaced with a handheld electronic system for simultaneous detection of the a panel of biomarkers to monitor the progression of skeletal muscle atrophy due to disuse under microgravity in long-duration spaceflights; and (2) use such quantitative information to guide the combined countermeasures of physical exercise and pharmaceuticals (i.e. specific protease inhibitors) so that the intensity, duration and frequency of exercise can be reduced. Note: The presentation includes voice commentary and plays best as a slide show. The voice begins once the presentation starts, and only requires the user to click to the next slide each time. With a run time of ~15 mins.

Biosensor↗

NASA NTRSDate not supplied

Monitoring Biomarkers for Muscular Atrophy using an Electronic Chip for Astronaut Health

Biosensing↗

NASA NTRSDate not supplied

Informing New Concepts for UAS and Autonomous System Safety Management using Disaster Management and First Responder Scenarios

As emerging flight operations become more prevalent and increasingly automated and distributed, the capabilities for managing safety of vehicles and operations will also need to evolve. To address this challenge, the National Academies has envisioned an In-Time Aviation Safety Management System (IASMS) capability for a wide range of aviation operations including current commercial operations as well as new entrants envisioned with advanced air mobility (AAM). The suite of IASMS services, functions, and capabilities (SFCs) would be implemented in a federated approach and would address trends as well as individual operations. Through predictive modeling and data analysis, IASMS is envisioned to identify arising risks so that they can be mitigated, in-time, before a safety incident occurs. IASMS and its requisite set of SFCs must leverage a wide range of information to perform. To better understand these new needs, FSF worked with the aviation and humanitarian communities to develop and validate scenarios that include traditional aviation operations and UAS operations intermingled as they are deployed for disaster management and first responder (DMFR) situations. The three scenarios developed include: • Post Natural disaster response, such as a hurricane, involving multiple parties utilizing traditional aviation and UAS to support rescue operations, surveil damage, and locate survivors needing assistance. • Wildfire fighting in remote locations with traditional aircraft for transport and fire-retardant delivery combined with UAS for surveillance of fire locations as well as to track individual firefighter locations. • Medical Operations and AAM in Urban Environments including passenger-carrying helicopters and AAM vehicles, medical missions (such as transport of radio-pharmaceuticals), and other UAS delivery operations (such as the delivery of defibrillators). Each scenario was developed and validated by representatives with expertise in humanitarian operations, urban and rural emergency response, air traffic management, UAS operations, and traditional flight operations. The scenario definitions address roles and responsibilities of individual actors, the appropriate utilization of UAS, and the actions taken by those actors to appropriately manage risks associated with the mission and environment. The risks to aviation traffic and to people on the ground explored included potential risks arising from incompatibilities in calculating reference altitudes (eg, differing uses of AGL, MSL, barometric, or GPS-derived values), loss of command and control (C2) communications, rapid changes in weather and winds, and physical interference. For each risk, IASMS SFCs were postulated in the context of monitoring services, risk assessment capabilities, and identifying appropriate mitigation strategies. The identified SFC capabilities were envisioned from known services postulated for IASMS and for UTM. For these unique environments, IASMS SFCs are needed to address conditions such as hazardous payloads, micro-climates and urban canyons, and the need to keep uninvolved air traffic out of the area where DMFR operations are being conducted. The second phase of analysis focused on inferring the specific information needs and the SFCs for IASMS, utilizing a structure of 16 information classes to organize requirements. For each of the risks identified in the workshops, it was postulated what data sources would be necessary to monitor critical aspects of the risk (eg, surrounding air traffic, ground population, terrain, etc). to be directly measured as well as data that would be derived, which implies additional SFCs for different actors to understand what information would likely be exchanged between parties. For an IASMS to be effective, additional research is needed to develop the advanced algorithms that can address the increasingly autonomous and complex operations in differing environments and to develop means of identifying unknown risks. Looking at these scenarios highlighted a number of research issues. These include the ability to quickly "cordon off" airspace thru temporary flight restrictions (TFRs) or other means, developing clear definitions to enable automation-based algorithms for prioritizing operations, defining airspace density metrics, standardization of altitude reporting, and establishing a basis for safety data metrics definition and collection. This paper seeks to outline the development of an IASMS in the context of the DMFR scenarios and resulting demonstrations. Utilizing this contextual approach, NASA will generate recommendations for an assured safety framework for AAM operations that enables AAM operations to safely access the NAS.

In Time Aviation Safety Management System↗

NASA NTRS2021

Western Montana Ecological Forecasting: Modeling Habitat Suitability of Mustelid Species to Guide Detection Dog Surveys for Contaminants Monitoring, via Collected Scats in River Systems of Western Montana

Environmental contaminants are becoming increasingly prevalent in riverine ecosystems. The status of contaminants in western Montana’s relatively pristine river systems is largely unknown. Monitoring for heavy metals, brominated flame-retardants (BFRs), and pharmaceuticals is important due to their negative effects on ecosystems. Exposure to these contaminants can have significant endocrine, neurological, and reproductive effects. Contaminants easily travel up the food chain and bioaccumulate in apex predators. As predators with a largely aquatic diet, American mink (Mustela vison) and North American river otter (Lontra canadensis) serve as reliable indicator species of environmental health and the status of contaminants. Analysis of scat from these species is a noninvasive method to measure contaminant levels, and detection dogs from Working Dogs for Conservation (WD4C) have been used to locate these scat samples. To aid in the search of these samples, habitat suitability models were created for mink and otter for the years 2013-2020 and projected to 2040 using the random forest algorithm in the Software for Assisted Habitat Modeling (SAHM). Predictor variable data were acquired from Landsat 8 Operational Land Imager (OLI), Terra Moderate Resolution Imaging Spectroradiometer (MODIS), Global Precipitation Measurement Integrated Multi-satellite Retrievals for GPM (GPM IMERG), Shuttle Radar Topography Mission (SRTM), and Soil Moisture Active Passive (SMAP). Within these models, the most important variable for mink and otter habitat was distance to river. Suitable habitat also corresponded with emergent herbaceous land cover and deeper river locations. These habitat suitability models will inform sampling site section for further contaminant analysis.

Anna Winter↗

NASA NTRS2021

LMI Automated Air Cargo Operations Market Research and Forecast

Air cargo companies and aircraft manufacturers are making significant investments to enable the movement of cargo via various levels of automated aircraft, such as aircraft with simplified operations requiring a pilot, remotely monitored or piloted aircraft, and fully autonomous aircraft. These investments will enable greater utilization of aircraft while unlocking new air markets traditionally served by ground transportation only. Many cargo companies and aerospace experts envision an operating environment where a single pilot can remotely pilot numerous aircraft for significant increases in aircraft utilization. The future operating environment is also expected to include air cargo companies flying smaller aircraft from airports and distribution centers outside of major U.S. cities directly to city centers, avoiding congested roads and increasing the velocity of cargo shipments, particularly those that are high-value, time-sensitive, and security sensitive (e.g., pharmaceuticals). These are just a few benefits and use cases cargo companies and aerospace experts see with the advancement of automated aircraft. To better understand industry’s direction, NASA asked the LMI team to research the forecasted market, timeline, risks, and opportunities for integrating unmanned air cargo vehicles into the National Airspace System (NAS) for the development and prioritization of the NASA Air Traffic Management Exploration’s research portfolio. To begin the market assessment, we gathered data via numerous interviews with key stakeholders and subject matter experts and literature reviews. We then incorporated the data into a custom-developed systems dynamics model and visualization dashboard. The systems dynamics model classifies the size of the market (e.g., overall fleet size of automated aircraft) for four distinct use cases over the next 20 years. The model projects the year in which various types of automated aircraft will enter the commercial cargo market based on our team’s collective research on when the aircraft will become viable due to manufacturing and certification timelines and the lifespan of current, traditional aircraft in service, to name a few factors. While this report defines our team’s estimated timeline of entry and growth, the model is dynamic—it enables NASA users to change variables based on future-year events. If the necessary technology does not mature in accordance with our assumptions, then NASA can change the entry of service point to a future year to evaluate the changes in market size in the out years. This flexibility will be key to deciding when and how NASA should invest in various areas.

air traffic management↗

NASA NTRSDate not supplied

Clean is not Sterile: A Planetary Science and Planetary Protection Perspective on Cleanroom Microbiology at NASA

The Astromaterials Acquisition and Curation Office at NASA is responsible for the curation of extraterrestrial samples from NASA’s past and future sample return missions. Our office curates samples from the moon, meteorites, comets, asteroids, cosmic dust and solar wind particles. All these samples are kept in cleanrooms to limit particulate and trace metal contamination, but none of these cleanrooms are specifically designed to control microbial contamination. During the early Apollo missions NASA scientists were very concerned with protecting the Earth from potential microbial contamination from the moon and with protecting the lunar samples from terrestrial microbes. NASA developed specialized equipment and clean rooms to keep these collections pristine. However, as we learned more about the lunar environment our concerns about microbial contamination lessened. Today none of the existing collections have microbial contamination requirements because they are not considered susceptible to microbial alteration under curation conditions (e.g. solar wind samples, and lunar samples) or have already been contaminated by terrestrial biology (meteorites collected in Antarctica). However, NASA’s OSIRIS-REx mission will land in 2023 with samples from a carbon rich asteroid that will be susceptible to microbial alteration. The Perseverance rover on Mars will begin to collect and cache samples that will be returned to Earth as soon as 2031. Martian samples may contain signs of extraterrestrial life and will have to be treated like the early Apollo samples. Martian samples will be isolated to protect the Earth, and must also be protected from terrestrial contamination. I will present microbial monitoring data from existing NASA cleanrooms and discuss how NASA is planning to use techniques from the pharmaceutical industry and academia to design new laboratories and equipment that will protect astromaterials and the earth from unwanted microbial contamination. I will also discuss a project to sample the external microbiome of the International Space Station. Results from this research will be used to design facilities for use on Mars that limit the amount of contamination associated with crewed missions.

Aaron B Regberg↗

NASA NTRSDate not supplied

ExMC Ground-Based Space Radiation Analog Pilot Drug Stability Studay: Final Data Review

Uncertainty regarding space radiation effects on medication degradation and potency remains high, though early data suggest that space radiation may affect the potency and quality of some pharmaceuticals. In the absence of empirical spaceflight measurements to characterize this risk area for long-duration planetary missions, high-fidelity ground-based targeted radiation analogs could provide valuable insights. The NASA Human Research Program's (HRP) Exploration Medical Capability (ExMC) Element conducted a pilot study to characterize the chemical stability of four selected medications exposed to rapid switching, mixed-species simulated galactic cosmic radiation (GCR) beams at the NASA Space Radiation Laboratory (NSRL), at Brookhaven National Laboratory (BNL). The research objective was to compare the effects of simulated GCR beam exposures on drug stability to those previously observed following spaceflight.

Vernie R Daniels↗

NASA NTRSDate not supplied

Electromagnetic Pain Relief/Blocking: Feasibility Assessment

CONTEXT/BACKGROUND Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves. OBJECTIVE/PURPOSE The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions. DATA SOURCES Due to the COVID-19 pandemic and the resulting closure of libraries, data sources were restricted to those available digitally. Online database searches included PubMed, U.S. Patent and Trademark Office, federal grant award databases (National Aeronautics and Space Administration (NASA), Department of Defense (DoD), National Institutes of Health (NIH)), and general internet searches. More than 1,600 records were reviewed in this effort. STUDY SELECTION/ELIGIBILITY CRITERIA Targeted searches included different aspects of pain management. Priority was given to review studies, to cover as much of the available literature as possible in this limited effort. STUDY APPRAISAL AND SYNTHESIS METHODS/DATA EXTRACTION AND DATA SYNTHESIS The titles of the studies and the awards that were obtained by searching online databases were reviewed and further information was sought for the relevant titles. Abstracts or award summaries were generally available online; for journal abstracts, full text articles were either available online or were requested via interlibrary loan. RESULTS An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified. LIMITATIONS This current effort, although extensive, did not identify a comprehensive list of all alternatives for pain treatment. Once the pandemic limitations are lifted, a longer, more thorough effort may find additional options. CONCLUSIONS/IMPLICATIONS The ideal electromagnetic pain treatment device for use on exploration-class spaceflight missions does not yet exist, but it may be available soon. It is not feasible for NASA to develop medical devices due to the schedule constraints for pending exploration-class missions, but adapting a promising device that is already FDA-approved might be an option. Monitoring research that is ongoing at other federal agencies is recommended, and further review of the candidate PSWT device identified in this current effort may be warranted.

C A Mullenax↗

NASA NTRS2021

Microbial Food Safety in Space Production Systems

While traveling to deep space is difficult for many reasons, food is a crucial one. Round-trip Mars mission scenarios last 3 years, demanding food with a shelf-life of 5 years; this means that feeding human crew sustainably for long-duration missions beyond low Earth orbit (LEO) will ultimately lead to a paradigm shift away from the current Earth-based food production system, which depends upon storing and transporting prepackaged foods, and toward bio-regenerative production of food in space. Pharmaceuticals and nutritional supplements face similar challenges. Moreover, the methods we currently use to detect dangerous microbes in food require sample return to Earth, a situation not viable for deep-space missions. While the science behind generating foods and bioproducts is covered by other white papers, in this paper we discuss a crucial gap uniting all of them: how to ensure that such products are free of unwanted microbial contamination and safe for crew to consume. Because Earth-based food safety systems cannot be directly applied in space, safety assurance is currently a critical bottleneck in the space production of food and other bioproducts. Future sustainable deep-space missions will require NASA to devote more resources in the coming decade to understanding the biological and physical science principles underlying microbial food safety in space, and to developing efficient, reliable methods in this area.

microbiology↗

NASA NTRS2021

Topical: Boiling, Condensation and Two-Phase Flows in Microgravity

The white paper addresses both fundamental and technological questions in the science of phase-change fluid flows aimed at understanding thermal transport in flow boiling and condensation and the use of these processes in space and terrestrial thermal systems. While flow boiling and condensation are widely employed in Earth-based thermal equipment to reduce the cost, size, and power required to transfer heat, a lack of data and predictive models on the impact of gravity on these phenomena hinders the use of two-phase heat transport in a low-gravity environment. The white paper presents research tasks in long-duration microgravity recommended to expand our knowledge on phase-changing flows. Due to elimination of the masking gravity effects, the proposed research will provide a unique opportunity to bring new insights into the role of capillary and hydrodynamic forces in phase-changing flows. The potential impact of the proposed research ranges from the space power, thermal and cryogenic systems to various terrestrial applications in the petrochemical, pharmaceutical, biochemical, nuclear, and metallurgical industries.

Phase-change fluid flow↗